Should We Encourage the 'Old' Therapies for MS?Should We Encourage the 'Old' Therapies for MS?

Would patients with RRMS do better by continuing with interferon beta or glatiramer acetate treatment over the long-term, instead of switching to a newer therapeutic regimine? Journal of Neurology, Neurosurgery, and Psychiatry
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news